Solstice Oncology, Inc.
Biotechnology · BOSTON, MA
BiotechnologySEC Form D
Solstice Oncology, Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 9, 2026, reporting $121,260,306 raised toward a $298,400,851 offering.
Incorporated in Delaware and based in BOSTON, MA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Solstice Oncology, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- CAROLINE LOEWExecutive Officer · Director · Promoter
- EMILY MINKOWDirector
- ANDREW LEVINDirector
- MORGAN HALLERDirector
- JULIE GRANTDirector
- Maiken Keson-BrookesExecutive Officer
- David FeltquateExecutive Officer
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised